[at Seeking Alpha] – Seven Year Average Revenue Growth Rate: 4.2%Seven Year Average EPS Growth Rate: 1.6%Seven Year Average Dividend Growth Rate: 9.4%Current Dividend Yield: 2.83%Balance Sheet Strength: Perfect
Read more on this.
Johnson & Johnson (JNJ), with a current market cap of $262.05B, started trading this morning at $93.27.
Looking at today’s trading action, the company’s one day range from $92.82 to $93.45 with a trailing 52-week range being $68.51 to $94.42.
JNJ shares are currently priced at 16.86x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 11.96x forward p/e ratio.
And for those looking to make a return holding the stock, the company pays shareholders $2.64 per share annually in dividends, yielding 2.90%.
In a review of the consensus earnings estimate this quarter, 16 sell-side analysts are looking at $1.20 per share, which would be $0.01 better than the year-ago quarter and a $0.02 sequential decrease. Investors should also note that the full-year EPS estimate of $5.48 is a $0.38 better when compared to the previous year’s annual results.
The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $17.94 Billion. If realized, that would be a 2.16% increase over the year-ago quarter.
Deutsche Bank downgraded JNJ from Buy to Hold (Jul 17, 2013).
Previously, Deutsche Bank upgraded JNJ from Hold to Buy.
When considering if perhaps the stock is under or overvalued, the average price target is $94.96, which is 1.81% above where the stock opened this morning.
Johnson & Johnson (NYSE:JNJ), together with its subsidiaries, engages in the research and development, manufacture and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical and Medical Devices and Diagnostics.
Tag Helper ~ Stock Code: JNJ | Common Company name: Johnson & Johnson | Full Company name: Johnson & Johnson (NYSE:JNJ) .